Quantinno Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$187K Buy
+16,267
New +$227K ﹤0.01% 3529
2026
Q2
– Sell
-22,982
Closed -$336K – 3454
2026
Q1
$336K Buy
+22,982
New +$367K ﹤0.01% 2970

Other funds holding CRVS

Quantinno Capital Management's CRVS Position: Q3 2026 in Review

Quantinno Capital Management opened a new position in Corvus Pharmaceuticals (CRVS) in Q3 2026: 16,267 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #3529 among its holdings. This is a return to the name: Quantinno Capital Management previously reported a position in CRVS as recently as Q1 2026.

Quantinno Capital Management first reported a position in CRVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $336K in Q1 2026. 177 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.

  • Quantinno Capital Management held 16,267 shares of Corvus Pharmaceuticals worth $187K as of Q3 2026.
  • Corvus Pharmaceuticals was a new Quantinno Capital Management position in Q3 2026.
  • Corvus Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3529 holding.
  • Quantinno Capital Management first reported a position in Corvus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Quantinno Capital Management's Corvus Pharmaceuticals position peaked at $336K in Q1 2026.
  • 177 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.